Goldman Sachs Raises Insmed PT to $225, Maintains Buy Rating

viernes, 31 de octubre de 2025, 2:18 pm ET1 min de lectura
INSM--

Goldman Sachs Raises Insmed PT to $225, Maintains Buy Rating

Goldman Sachs Raises Insmed PT to $225, Maintains Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios